Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study.

Righini, Marc; Robert-Ebadi, Helia; Elias, Antoine; Sanchez, Olivier; Le Moigne, Emmanuelle; Schmidt, Jeannot; Le Gall, Catherine; Cornuz, Jacques; Aujesky, Drahomir; Roy, Pierre-Marie; Chauleur, Céline; Rutschmann, Olivier T; Poletti, Pierre-Alexandre; Le Gal, Grégoire (2018). Diagnosis of Pulmonary Embolism During Pregnancy: A Multicenter Prospective Management Outcome Study. Annals of internal medicine, 169(11), pp. 766-773. American College of Physicians 10.7326/M18-1670

[img] Text
Righini-2018-Diagnosis of Pulmonary Embolism D.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (206kB) | Request a copy

Background

Data on the optimal diagnostic management of pregnant women with suspected pulmonary embolism (PE) are limited, and guidelines provide inconsistent recommendations on use of diagnostic tests.

Objective

To prospectively validate a diagnostic strategy in pregnant women with suspected PE.

Design

Multicenter, multinational, prospective diagnostic management outcome study involving pretest clinical probability assessment, high-sensitivity D-dimer testing, bilateral lower limb compression ultrasonography (CUS), and computed tomography pulmonary angiography (CTPA). (ClinicalTrials.gov: NCT00740454).

Setting

11 centers in France and Switzerland between August 2008 and July 2016.

Patients

Pregnant women with clinically suspected PE in emergency departments.

Intervention

Pulmonary embolism was excluded in patients with a low or intermediate pretest clinical probability and a negative D-dimer result. All others underwent lower limb CUS and, if results were negative, CTPA. A ventilation-perfusion (V/Q) scan was done if CTPA results were inconclusive. Pulmonary embolism was excluded if results of the diagnostic work-up were negative, and untreated pregnant women had clinical follow-up at 3 months.

Measurements

The primary outcome was the rate of adjudicated venous thromboembolic events during the 3-month follow-up.

Results

441 women were assessed for eligibility, and 395 were included in the study. Among these, PE was diagnosed in 28 (7.1%) (proximal deep venous thrombosis found on ultrasonography [n = 7], positive CTPA result [n = 19], and high-probability V/Q scan [n = 2]) and excluded in 367 (clinical probability and negative D-dimer result [n = 46], negative CTPA result [n = 290], normal or low-probability V/Q scan [n = 17], and other reason [n = 14]). Twenty-two women received extended anticoagulation during follow-up, mainly for previous venous thromboembolic disease. The rate of symptomatic venous thromboembolic events was 0.0% (95% CI, 0.0% to 1.0%) among untreated women after exclusion of PE on the basis of negative results on the diagnostic work-up.

Limitation

There were several protocol deviations, reflecting the difficulty of performing studies in pregnant women with suspected PE.

Conclusion

A diagnostic strategy based on assessment of clinical probability, D-dimer measurement, CUS, and CTPA can safely rule out PE in pregnant women.

Primary Funding Source

Swiss National Foundation for Scientific Research, Groupe d'Etude de la Thrombose de Bretagne Occidentale, and International Society on Thrombosis and Haemostasis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of General Internal Medicine (DAIM) > Clinic of General Internal Medicine

UniBE Contributor:

Aujesky, Drahomir

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0003-4819

Publisher:

American College of Physicians

Language:

English

Submitter:

Tobias Tritschler

Date Deposited:

18 Jan 2019 11:18

Last Modified:

05 Dec 2022 15:24

Publisher DOI:

10.7326/M18-1670

PubMed ID:

30357273

BORIS DOI:

10.7892/boris.123193

URI:

https://boris.unibe.ch/id/eprint/123193

Actions (login required)

Edit item Edit item
Provide Feedback